10 Best Future Stocks For The Long-Term

8. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 80

Johnson & Johnson (NYSE:JNJ) is a leading pharmaceutical company that ranks eighth on our list of the best future stocks in the long term. Johnson & Johnson’s (NYSE:JNJ) also has stakes in biotechnology and medical technologies.

In the second quarter of 2024, the company reported sales of $22.4 billion, up 4.3%. Johnson & Johnson (NYSE:JNJ) not only saw success with regulatory approvals for some medications but expanded its footprint in biotechnology. Previously in April, Johnson & Johnson (NYSE:JNJ) acquired Shockwave Medical, a cardiovascular medical device company, enhancing the company’s position in cardiovascular intervention and medical technology. Overall, its MedTech segment logged $8 billion in sales worldwide, up by 4.4% year-over-year.

Johnson & Johnson (NYSE:JNJ) is one of the best future stocks to buy because of its role in medical technology and its growth trajectory across all its departments over the years. The company is expected to deliver over 20 novel therapies and has over 50 product expansions in-store by 2030.

In addition to that, its segments are expected to grow at a compound annual growth rate of 5% to 7%, explaining why analysts are bullish on the company. Analysts 12-month median price target of $170 points to a 2% upside from current levels. Overall, JNJ was held by 80 hedge funds at the close of Q2 2024 and Fisher Asset Management was the largest shareholder with a position worth $1.02 billion.